Hemagglutination assay

Hemagglutination assay

Hemagglutination assay is a laboratory method used to measure the concentration of viruses, bacteria, or antibodies that cause agglutination of red blood cells (RBCs). This assay is based on the principle that certain viruses or bacteria possess Hemagglutinin proteins on their surface, which can bind to receptors on the surface of RBCs, leading to the clumping or agglutination of the cells. Similarly, antibodies that target these hemagglutinin proteins can also cause agglutination when mixed with a solution containing the appropriate virus or bacteria. The degree of agglutination is an indicator of the concentration of the agglutinating agent (virus, bacteria, or antibody) in the sample.

Principle

The hemagglutination assay operates on the principle that a single virus particle or bacterium with multiple agglutinin sites can bind to more than one RBC, forming a network of cells that appears as a lattice or mat in the test well. In the absence of sufficient agglutinating agents, RBCs settle out in a well-defined dot at the bottom of the well due to gravity. The presence and strength of agglutination can be visually assessed and quantified, providing a measure of the amount of agglutinating agent present.

Applications

Hemagglutination assays are widely used in virology for the quantification and identification of viruses, especially those that are known to agglutinate RBCs, such as influenza, Parvovirus, and certain Coronaviruses. In bacteriology, it is used for the detection of certain bacteria that possess hemagglutinating properties. Additionally, this assay is employed in the diagnosis of viral infections and in blood typing, where it helps in identifying the ABO blood group and the presence of specific antibodies that may cause transfusion reactions.

Types of Hemagglutination Assays

There are several types of hemagglutination assays, including:

• Direct Hemagglutination: Used to detect viruses or bacteria that naturally agglutinate RBCs.
• Passive Hemagglutination: Involves the coating of RBCs with antigens not naturally present on their surface, followed by the addition of serum containing antibodies against those antigens.
• Hemagglutination Inhibition: Used to measure the ability of antibodies in a patient's serum to inhibit the agglutination of RBCs by a specific virus, indicating previous exposure or immunity to that virus.

Procedure

The basic procedure for a hemagglutination assay involves: 1. Preparation of a 2% suspension of RBCs in a saline solution. 2. Serial dilution of the sample (virus, bacteria, or serum) in a microtiter plate. 3. Addition of the RBC suspension to each well. 4. Incubation at room temperature for a specified period, usually 1-2 hours. 5. Observation and recording of agglutination patterns.

Interpretation

The highest dilution of the sample that still causes visible agglutination of RBCs is considered the endpoint of the assay. This dilution factor can be used to calculate the concentration of the agglutinating agent in the original sample.

Limitations

While the hemagglutination assay is a valuable tool in microbiology and immunology, it has limitations. It is not suitable for all types of viruses or bacteria, particularly those that do not possess hemagglutinating properties. Additionally, the assay requires careful interpretation, as non-specific agglutination can occur, leading to false-positive results.

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian